Paul Murphy, MD
Urology · Monroe, LANPI 1578822557
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,114 of the $11,349 with a category attached, or 71.5%. Intuitive Surgical accounts for 95.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $10,062 and has fallen 98.9% since, to $115 in 2025.
Across 34 payments — averaging $333.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- Urogen Pharma, Inc.$142
- Astellas Pharma US Inc$100
- Johnson & Johnson$63
- Teleflex LLC$33
- Coloplast$30
- plus $188 from 9 others
What the payments were for
- Travel & lodging$2,13919%
- Food & beverage$1,09610%
- Education$8,11471%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $10,792 |
| Urogen Pharma, Inc. | 6 | $142 |
| Astellas Pharma US Inc | 1 | $100 |
| Johnson & Johnson | 1 | $63 |
| Teleflex LLC | 1 | $33 |
| Coloplast | 1 | $30 |
| 180 Medical, Inc. | 2 | $29 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Endo USA, Inc. | 1 | $18 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,690
How this compares
$11,349 in reported general payments places this provider in the 85th percentile of 199 urology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $12,658 |
| Tamsulosin Hcl | 241 | $3,364 |
| Oxybutynin Chloride ErOxybutynin Chloride | 141 | $3,326 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 61 | $2,646 |
| Finasteride | 117 | $2,309 |
| Desmopressin Acetate | 29 | $1,189 |
| Estradiol | 13 | $1,185 |
| Solifenacin Succinate | 36 | $1,027 |
| NitrofurantoinNitrofurantoin Macrocrystal | 25 | $849 |
| Potassium Citrate ErPotassium Citrate | 17 | $838 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 58 | $349 |
| Ciprofloxacin Hcl | 78 | $318 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $140 |
| Fluconazole | 18 | $134 |
| Oxybutynin Chloride | 16 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $100 | $12,65818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 199 urology providers in Louisiana.
Other urology in Monroe
- Odell DeanMonroe$7K
- Richard VanlangendonckNew Orleans$289K
- Gerard HenryBossier City$256K
- Ralph HendersonShreveport$211K
- Wayne HellstromNew Orleans$183K
- Colin GoudelockeNew Orleans$124K
- Sunil PurohitCovington$99K
- Raju ThomasNew Orleans$67K
- Louis KraneNew Orleans$62K
- Kevin HebertShreveport$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.